Piramal Pharma received a $360 million investment from US private equity company Carlyle Group in October 2020 in exchange for a 20% share. Piramal Pharma includes the contract development and manufacturing organisation, called the Piramal Pharma Solutions (PPS), which contributes three-fifths to the revenue.
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/SomJqD0
https://ift.tt/tDvgOb5
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/SomJqD0
https://ift.tt/tDvgOb5
Post a Comment